Cigna Corporation
CI | NYSE
$292.09
-$6.14 (-2.06%)
Nov 2, 2026, 11:00 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 274.95B | 247.12B | 195.27B | 180.52B | 174.07B | 160.4B |
Cost of Revenue | 248.97B | 221.16B | 170.09B | 157.02B | 151.12B | 136.19B |
Gross Profit | 25.99B | 25.96B | 25.18B | 23.5B | 22.95B | 24.21B |
Operating Income | 9.13B | 9.42B | 8.54B | 8.45B | 7.94B | 8.15B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 7.59B | 5.27B | 5.51B | 8.4B | 6.79B | 10.87B |
Net Income | 5.96B | 3.43B | 5.16B | 6.7B | 5.37B | 8.46B |
Selling & General & Admin | 14B | 14.57B | 14.32B | 13.05B | 12.79B | 13.66B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 2.86B | 1.98B | 2.32B | 2.01B | 2.22B | 2.39B |
Operating Expenses | 16.86B | 16.55B | 16.64B | 15.05B | 15.01B | 16.05B |
Interest Expense | 1.38B | 1.44B | 1.45B | 1.23B | 1.21B | 1.44B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 265.82B | 237.7B | 186.73B | 172.07B | 166.13B | 152.25B |
Income Tax Expense | 1.35B | 1.49B | 141M | 1.62B | 1.37B | 2.38B |
Shares Outstanding (Basic) | 265.95M | 280.29M | 296.88M | 313.07M | 337.96M | 364.98M |
Shares Outstanding (Diluted) | 265.95M | 283.22M | 296.88M | 313.07M | 340.97M | 368.39M |
EPS (Basic) | 22.30 | 12.25 | 17.57 | 21.66 | 15.89 | 23.17 |
EPS (Diluted) | 22.17 | 12.12 | 17.39 | 21.41 | 15.75 | 22.96 |
EBITDA | 11.61B | 11.45B | 10.85B | 10.44B | 9.96B | 10.37B |
EBIT | 8.97B | 9.69B | 9.03B | 8.58B | 8.16B | 8.57B |
Depreciation & Amortization | 2.63B | 1.75B | 1.81B | 1.86B | 1.8B | 1.8B |
Add to Watchlist
Select watchlists to add or remove CI